CoChat
Cited by 114

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease

Hope, Holly F., Binkley, George M., Fenton, Sally, Kitas, George D., Verstappen, Suzanne M. M., Symmons, Deborah P. M. · 2019 · PLOS ONE

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0201196

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 44

  1. J Hippisley-Cox, 2017, Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study, BMJ, 357, j2099, 10.1136/bmj.j2099 · DOI · Paper page
  2. TJ Wang, 2003, A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community, A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community, 290, 1049
  3. R Ofori-Asenso, 2017, Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysis, Journals Gerontol Ser A, 73, 813, 10.1093/gerona/glx169 · DOI · Paper page
  4. L Degli Esposti, 2012, Adherence to Statin Treatment and Health Outcomes in an Italian Cohort of Newly Treated Patients: Results From an Administrative Database Analysis, Clin Ther, 34, 190, 10.1016/j.clinthera.2011.12.011 · DOI
  5. JH Watanabe, 2013, Revisiting the medication possession ratio threshold for adherence in lipid management, Curr Med Res Opin, 29, 175, 10.1185/03007995.2013.766164 · DOI
  6. T Xu, 2017, Statin Adherence and the Risk of Stroke: A Dose-Response Meta-Analysis, CNS Drugs, 31, 263, 10.1007/s40263-017-0420-5 · DOI
  7. A Dragomir, 2010, Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting, Value Heal, 13, 87, 10.1111/j.1524-4733.2009.00583.x · DOI
  8. E Aarnio, 2015, Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence—Estimates from the Finnish prescription register, Atherosclerosis, 239, 240, 10.1016/j.atherosclerosis.2014.12.059 · DOI
  9. S Clifford, 2008, Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework, J Psychosom Res, 64, 41, 10.1016/j.jpsychores.2007.05.004 · DOI · Paper page
  10. M Lemstra, 2012, Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis, Can J Cardiol, 28, 574, 10.1016/j.cjca.2012.05.007 · DOI · Paper page
  11. WH Xu, 2016, Relationship between statin adherence and long-term clinical consequences in patients with cardiovascular disease: A systematic review and meta-analysis, Int J Clin Exp Med, 9, 9195
  12. S Deshpande, 2017, A systematic review to assess adherence and persistence with statins, Curr Med Res Opin, 33, 769, 10.1080/03007995.2017.1281109 · DOI
  13. IM Kronish, 2016, Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults, Circ Cardiovasc Qual Outcomes, 9, 364, 10.1161/CIRCOUTCOMES.115.002418 · DOI
  14. HF Hope, 2016, Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes, RMDOpen, 2, e000171
  15. JA Rash, 2016, A systematic review of interventions to improve adherence to statin medication: What do we know about what works?, Prev Med (Baltim), 90, 155, 10.1016/j.ypmed.2016.07.006 · DOI
  16. A Endo, 2010, A historical perspective on the discovery of statins, Proc Jpn Acad Ser B Phys Biol Sci, 86, 484, 10.2183/pjab.86.484 · DOI · Paper page
  17. M Al-Foraih, 2017, Factors Affecting Adherence to Statins in Hypercholesterolemic Kuwaiti Patients: A Cross-Sectional Study, Med Princ Pract, 26, 35, 10.1159/000450644 · DOI
  18. MJ Braamskamp, 2015, Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence, Paediatr Drugs, 17, 159, 10.1007/s40272-014-0116-y · DOI
  19. TN Harrison, 2013, Primary nonadherence to statin therapy: patients’ perceptions, Am J Manag Care, 19, e133
  20. E Aarnio, 2016, Socioeconomic Inequalities in Statin Adherence Under Universal Coverage. Does Sex Matter?, Circ Cardiovasc Qual Outcomes, 9, 704, 10.1161/CIRCOUTCOMES.116.002728 · DOI
  21. HA Batal, 2007, Impact of prescription size on statin adherence and cholesterol levels, BMC Heal Serv Res, 7, 175, 10.1186/1472-6963-7-175 · DOI
  22. CL Bryson, 2008, Alcohol screening scores and medication nonadherence, Ann Intern Med, 149, 795, 10.7326/0003-4819-149-11-200812020-00004 · DOI
  23. G Corrao, 2010, Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy, Clin Ther, 32, 300, 10.1016/j.clinthera.2010.02.004 · DOI
  24. H Halava, 2015, Influence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base, PLoS One, 10, e0130901, 10.1371/journal.pone.0130901 · DOI
  25. P Lavikainen, 2016, Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence, BMJ Open, 6, e011306, 10.1136/bmjopen-2016-011306 · DOI
  26. S Perreault, 2009, Impact of better adherence to statin agents in the primary prevention of coronary artery disease, Eur J Clin Pharmacol, 65, 1013, 10.1007/s00228-009-0673-0 · DOI
  27. S Perreault, 2009, Effect of statin adherence on cerebrovascular disease in primary prevention, Am J Med, 122, 647, 10.1016/j.amjmed.2009.01.032 · DOI
  28. DA Rublee, 2012, Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy, Am J Ther, 19, 24, 10.1097/MJT.0b013e3181ee707e · DOI
  29. JF Slejko, 2014, Adherence to statins in primary prevention: yearly adherence changes and outcomes, J Manag Care Pharm, 20, 51, 10.18553/jmcp.2014.20.1.51 · DOI
  30. H Wallach-Kildemoes, 2013, Adherence to preventive statin therapy according to socioeconomic position, Eur J Clin Pharmacol, 69, 1553, 10.1007/s00228-013-1488-6 · DOI
  31. S Farsaei, 2015, Adherence to statin therapy in patients with type 2 diabetes: An important dilemma, J Res Med Sci, 20, 109
  32. H Halava, 2014, Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities, CMAJ, 186, E449, 10.1503/cmaj.131807 · DOI
  33. DM Mann, 2007, Predictors of Adherence to Statins for Primary Prevention, Cardiovasc Drugs Ther, 21, 311, 10.1007/s10557-007-6040-4 · DOI
  34. RM Guthrie, 2001, The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program, Clin Ther, 23, 970, 10.1016/S0149-2918(01)80084-9 · DOI
  35. CS Stilley, 2004, Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment, Ann Behav Med, 27, 117, 10.1207/s15324796abm2702_6 · DOI · Paper page
  36. M Von Korff, 1992, A chronic disease score from automated pharmacy data, J Clin Epidemiol, 45, 197, 10.1016/0895-4356(92)90016-G · DOI · Paper page
  37. M Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg & Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  38. R Horne, 1999, Patients’ beliefs about treatment: the hidden determinant of treatment outcome?, J Psychosom Res, 47, 491, 10.1016/S0022-3999(99)00058-6 · DOI · Paper page
  39. L Casebeer, 2009, Improving the physician-patient cardiovascular risk dialogue to improve statin adherence, BMC Fam Pract, 10, 48, 10.1186/1471-2296-10-48 · DOI
  40. M Kooy, 2013, Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial, Front Pharmacol, 4
  41. YJ Chee, 2014, Understanding patients’ perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review, Singapore Med J, 55, 416, 10.11622/smedj.2014099 · DOI · Paper page
  42. NK Kalia, 2006, Visualizing coronary calcium is associated with improvements in adherence to statin therapy, Atherosclerosis, 185, 394, 10.1016/j.atherosclerosis.2005.06.018 · DOI · Paper page
  43. PP Reese, 2016, Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes, J Gen Intern Med, 31, 402, 10.1007/s11606-015-3540-y · DOI
  44. AN de Cates, 2014, Fixed-dose combination therapy for the prevention of cardiovascular disease, Cochrane database Syst Rev, 4, CD009868

Cited by

See all 114

Metadata

Authors
Hope, H. F., Binkley, G. M., Fenton, S., Kitas, G. D., Verstappen, S. M. M., & Symmons, D. P. M.
Venue
PLOS ONE
Published
2019-01-17
Volume
14
Issue
1
Pages
e0201196
ISSN
1932-6203
Cited by
114
References
16
Language
en
Funders
  • Arthritis Research UK (16514)
  • British Heart Foundation (16514)
  • Pfizer UK (16514)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease. https://app.cochat.ai/papers/10.1371/journal.pone.0201196
The paper
Hope, H. F., Binkley, G. M., Fenton, S., Kitas, G. D., Verstappen, S. M. M., & Symmons, D. P. M. (2019). Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0201196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.